FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times The peptide problem: Hype is outrunning the evidence I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA